• Users Online: 232
  • Print this page
  • Email this page
 
ORIGINAL ARTICLE
Ahead of Print

In vivo Bioluminescence-based monitoring of liver metastases from colorectal cancer: An experimental model


1 Department of Medical and Surgical Sciences and Translational Medicine, Molecular Genetics Section, Sapienza University of Rome, Rome, Italy
2 Department of Cellular Biotechnology and Hematology, Molecular Genetics Section, Sapienza University of Rome, Rome, Italy
3 Department of Research, Advanced Diagnostic and Technological Innovation – Translational Research Area, Regina Elena National Cancer Institute, Rome, Italy
4 Advanced International Mini-invasive Surgery (AIMS) Academy, Ospedale Niguarda Ca' Granda, Milan, Italy
5 Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Modena, Italy
6 Department of Pathology, Sapienza University of Rome, Rome, Italy
7 Pasteur Institute Fondazione Cenci Bolognetti, Department of Biology and Biotechnology ‘Charles Darwin’, Sapienza University of Rome, Rome, Italy

Correspondence Address:
Giuseppe Nigri,
Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, Via Di Grottarossa 1035 00189, Rome
Italy
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/JMAU.JMAU_51_18

Background: In this study we aimed to develop a new in vivo bioluminescence-based tool to monitor and to quantify colon cancer (CC) liver metastasis development. Methods: HCT 116 cells were transducted with pLenti6/V5-DEST-fLuc for constitutive expression of firefly luciferase. Infection was monitored analyzing endogenous bioluminescence using the IVIS Lumina II In vivo Imaging System and a positive clone constitutively expressing luciferase (HCT 116-fLuc) was isolated. HCT 116-fLuc cells were left untreated or treated with 1 μM GDC-0449, a Hedgehog pharmacological inhibitor. Moreover, 1 x 106 HCT 116-fLuc cells were implanted via intra-splenic injection in nude mice. Bioluminescence was analyzed in these mice every 7 days for 5 weeks. After that, mice were sacrificed and bioluminescence was analyzed on explanted livers. Results: We found that in vitro bioluminescence signal was significantly reduced when HCT 116-fLuc cells were treated with GDC-0449. Regarding in vivo data, bioluminescence sources consistent with hepatic anatomical localization were detected after 21 days from HCT 116-fLuc intrasplenic injection and progressively increased until the sacrifice. The presence of liver metastasis was further confirmed by ex-vivo bioluminescence analysis of explanted livers. Conclusions: Our in vitro results suggest that inhibition of Hedgehog pathway may hamper CC cell proliferation and impel for further studies. Regarding in vivo data, we set-up a strategy for liver metastasis visualization, that may allow follow-up and quantification of the entire metastatic process. This cost-effective technique would reduce experimental variability, as well as the number of sacrificed animals.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Magistri P
    -  Battistelli C
    -  Toietta G
    -  Strippoli R
    -  Sagnotta A
    -  Forgione A
    -  Di Benedetto F
    -  Uccini S
    -  Vittorioso P
    -  D'Angelo F
    -  Aurello P
    -  Ramacciato G
    -  Nigri G
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed46    
    PDF Downloaded4    

Recommend this journal